Different batches [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2020-03-08 11:19 (999 d 12:30 ago) – Posting: # 21225
Views: 3,111

Hi Marcelo,

❝ I agree with you. It was just a suggestion based on our previous experience in Brazil :-|. Sometimes we need to explain the inexplicable to health authority to avoid delays in the dossier review :-D


The use of a different batch in the fed study as asked above from taiyab.jameel could be better as you can prove batches therpeutic equivalence consistency via in vivo studies.

On the contrary, in the case of additional strength biowaiver, it is a must to use the same biobatch for which the therpeutic equivalence was proven before via in vivo BE study.

Best regards,

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
22,424 posts in 4,694 threads, 1,600 registered users;
20 visitors (2 registered, 18 guests [including 7 identified bots]).
Forum time: 23:49 CET (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5